Hypoplastic left heart syndrome
Revision as of 18:51, 25 June 2017 by Lisayee25 (talk | contribs) (Created page with "thumb ==Background== * A congenital heart defect in which the left heart is severely underdeveloped *Accounts for 2 to 3 percen...")
Background
- A congenital heart defect in which the left heart is severely underdeveloped
- Accounts for 2 to 3 percent of all CHD [1]
Physiology
- With a diminutive LV, the RV must perfuse both pulmonary and systemic circulations
- Survival is dependent on:
Clinical Features
- Asymptomatic at birth because of adequate systemic perfusion through a PDA and initially high pulmonary vascular resistance
- As the PDA begins to close and pulmonary vascular resistance decreases, may develop hypotension, acidosis, and respiratory distress
- Symptoms can rapidly progress from cyanosis, increased respiratory distress, and poor feeding to heart failure and cardiogenic shock
Differential Diagnosis
Congenital Heart Disease Types
- Cyanotic
- Acyanotic
- AV canal defect
- Atrial septal defect (ASD)
- Ventricular septal defect (VSD)
- Cor triatriatum
- Patent ductus arteriosus (PDA)
- Pulmonary/aortic stenosis
- Coarctation of the aorta
- Differentiation by pulmonary vascularity on CXR[2]
- Increased pulmonary vascularity
- Decreased pulmonary vascularity
- Tetralogy of fallot
- Rare heart diseases with pulmonic stenosis
Evaluation
- Echocardiography
- Chest x-ray
- Cardiomegaly, increased pulmonary vasculature
- ECG
- Right axis deviation, RV hypertrophy
Management
- Stabilize cardiopulmonary function prior to surgery
- Maintain PDA to provide sufficient mixing of oxygenated and deoxygenated blood, and adequate systemic perfusion
- Prostaglandin E1
- Start infusion at 0.05 mcg/kg/min IV and titrate up to 0.1 mcg/kg/min, monitoring for hypotension and apnea
- Side Effects: Hypotension, Bradycardia, Seizures and Apnea
- Prostaglandin E1
- Staged surgical repair
- First stage (Norwood procedure) performed in neonates
- Second stage (bidirectional Glenn procedure) performed at 3-6 months
- Third stage (Fontan procedure) performed at 18-30 months
Disposition
- Admit
See Also
External Links
References
- ↑ Gordon BM. Decreasing number of deaths of infants with hypoplastic left heart syndrome. J Pediatr. 2008;153(3):354-8.
- ↑ Knipe K et al. Cyanotic congenital heart diseases. Radiopaedia. http://radiopaedia.org/articles/cyanotic-congenital-heart-disease